Systems Neurology Laboratory
Department of Neurology
Ulm University
Research Grant
“Converging disease mechanisms in amyotrophic lateral sclerosis: microRNAs and the Fragile-X protein family”
Co-Investigator: Axel Freischmidt
2023 - 2026
DFG-SFB1149/3 3rd funding period Projekt B05
“Circular RNAs in neurotrauma pathophysiology”
2023 - 2026
JPND Consortium
“DC4MND: Multidimensional mechanistic investigations of trans spinal direct current stimulation in motor neuron disease”
2023 - 2026
JPND Consortium
“HiCALS: Hypothalamic mechanisms of High-Calorie intervention in ALS”
2023 - 2026
TARGET-ALS Consortium
“Targeting hypermetabolism for ALS treatment”
2023 - 2025
Opus 18 Grant
“Mechanisms underlying the breakdown of homeostatic scaling between synaptic excitation and motoneuron excitability in mice displaying Amyotrophic Lateral Sclerosis”
Co-Investigator: Daniel Zytnicki
2021 - 2024
Research Grant
“Restoration of excitation/inhibition balance to modulate motoneuron degeneration in ALS”
Co-Investigator: Daniel Zytnicki
2021 - 2024
Research Grant
“Post-synaptic disruption drives motoneuron vulnerability and disease progression in ALS”
Co-Investigator: Tobias Böckers
2020 - 2022
Research Grant
“Serum Response Factor (SRF) regulates motoneuron vulnerability and activity-dependent neuroprotection in Amyotrophic Lateral Sclerosis”
Co-Investigator: Bernd Knöll
2020 - 2022
Thierry Latran foundation
“Hypothalamic alterations as a cause of weight loss and clinical progression in amyotrophic lateral sclerosis”
Co-investigator: Luc Dupuis
2019 - 2022
DFG-SFB1149/2 2nd funding period project B05
“Ethanol intoxication in TBI: mechanisms of neuroprotection and neuroglial modulation”
2019 - 2022
Thierry Latran foundation
“Translational modulation of synaptic inputs to MN through PKA-coupled receptors: brining excitation to the clinics”
2019 - 2022
Radala Foundation
“Synaptically-driven neuroprotection in ALS”
Co-investigator: Daniel Zytnicki
2019 - 2022
GRK1789 2nd funding period
“Co-investigator in the Cellular and Molecular Mechanisms of Aging (CEMMA) training group”
2018 - 2022
BMBF FKZ 01EW1705A
“Cortical microcircuitry after traumatic brain injury: molecules to networks”
2017 - 2020
Investigator-Initiated Research agreement with Bayer Ltd for the project
“FGFR inhibitors in acute and subacute trauma”
2017 - 2018
Baustein Program, University Ulm
“Genetic and Chemogenetic exploration of non-cell-autonomous pathways in motoneuron disease”
2016 - 2017
GRK1789
“Co-investigator in the Cellular and Molecular Mechanisms of Aging (CEMMA) training group”
2016 - 2017
DFG-SFB1149 (project B05)
“Ethanol intoxication as relevant comorbidity in Traumatic Brain Injury: innovative approaches to neuroprotection in TBI”
2015 - 2018
Baustein Program, University Ulm
“Chemogenetic exploration of neuroprotective pathways in motoneuron disease"
2015 - 2018
Research Agreement with Hoffmann-La Roche Ltd on the project
“CB2 receptor-mediated neuroprotection in preclinical models of Amyotrophic Lateral Sclerosis”
2015 - 2017
Synapsis Foundation Grant
“Chemogenetic approaches to investigate astrocyte role in Alzheimer´s Disease and ALS”
2014 - 2016